• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

DNDi and Rotary collaborate to prevent and treat diseases affecting neglected communities in Eastern Africa

Home > News

DNDi and Rotary collaborate to prevent and treat diseases affecting neglected communities in Eastern Africa

Prof. Sam Kariuki, DNDi Eastern Africa Director and Leonard Ithau, Rotary International District 9212 District Governor shaking hands
Prof. Sam Kariuki, DNDi Eastern Africa Director and Leonard Ithau, Rotary International District 9212 District Governor
29 Aug 2023

On 29 August 2023, Rotary Kenya and the non-profit medical research organization Drugs for Neglected Diseases initiative (DNDi) signed a five-year agreement to collaborate on research and access activities that support the health needs of neglected patients and communities.  

During the signing of the Memorandum of Understanding (MoU) held at the DNDi offices in Nairobi, Prof. Samuel Kariuki, the Eastern Africa Director, outlined the collaboration areas and their significance for Kenyan communities. 

‘This MoU is a great step forward in working together to reach grassroots communities as we raise awareness of the discovery and delivery of life-saving treatments for neglected populations. The synergy between DNDi and Rotary will empower communities through various activities, such as education campaigns on NTDs and other diseases, medical camps, and fundraising, among others,’ said Prof. Kariuki.  

Rotary Kenya, which operates in Kenya, Ethiopia, South Sudan, and Eritrea, is a constituent of Rotary District 9212 and part of Rotary International, a global non-profit service organization founded in 1905. They focus on seven areas of operation, including disease prevention, environmental conservation, and climate change, all of which have a significant connection to the diseases that DNDi seeks to address. 

2 people sign documents while 5 people stand behind them
Leonard Ithau, Rotary District 9212 Governor and Prof. Sam Kariuki, Eastern Africa Director, DNDi signing copies of the MoU. Looking on is Wairimu Njagi, District Governor Nominee; Dr Joe Kamau, District Governor Elect at Rotary District 9212; Simon Bolo, Head of Leishmaniasis Access, DNDi; and Lydia Manoti, Philanthropy Manager, DNDi.

‘Rotary Kenya and DNDi share some common goals. It is important that we explore partnerships to tackle the complex issues that communities face, create positive impact in the communities of operations, and serve their needs,’ said Leonard Ithau, Governor, Rotary District 9212.  

The main areas of cooperation will include: 

  • Creating awareness of neglected diseases through communication and information dissemination to the public and community leaders.  
  • Reinforcing and building on existing clinical capacities and addressing site infrastructure needs where necessary.  
  • Providing on-site training in clinical research and engaging in knowledge and skills sharing in the field of pharmaceutical R&D. 
  • Engaging in joint fundraising efforts for the benefit of neglected patients.  
  • Fostering deeper engagement between neglected disease experts and grassroots communities in Eastern Africa. 

Through this collaboration, Rotary Kenya and DNDi hope to make a significant difference in preventing and treating neglected tropical diseases by accelerating the development of new medicines and improving access to safe and effective treatments in the region. 

Group of people stand behind a table
From left to right: Joy Malongo, Access Manager, DNDi; Cherinet Adera, Senior Market Access Manager, DNDi; Wairimu Njagi, District Governor Nominee, Rotary; Linet Otieno, Head of Communications, DNDi; Dr Joe Kamau, District Governor Elect at Rotary District 9212; Leonard Ithau, Rotary District 9212 Governor; Prof. Sam Kariuki, Eastern Africa Director, DNDi; Simon Bolo, Head of Leishmaniasis Access, DNDi; Saum Siraj, Vice Chair, Community Services District 9212; Beryl Anyango, Executive Office Associate, DNDi; and Lydia Manoti, Philanthropy Manager, DNDi.
Partnership Strengthening Capacities Africa

Read, watch, share

Loading...
Statements
8 May 2025

DNDi’s briefing note for 78th World Health Assembly

Marco Krieger
News
30 Apr 2025

Message on the passing of Dr Marco Aurélio Krieger, Vice-President of Production and Innovation in Health, Fiocruz

Screening activities in village in Guinea
News
25 Apr 2025

Statements from Dr Luis Pizarro and Daisuke Imoto about the Hideyo Noguchi Africa Prize awarded to DNDi

Two man outside of a hospital talking with a nurse
Press releases
24 Apr 2025

Liverpool clinical trial aims to advance life-changing treatment for a deadly parasitic disease

Woman walking in a laboratory
Press releases
23 Apr 2025

DNDi welcomes GHIT support for new project with three Japanese universities to find drug candidates for Chagas disease

Stories
16 Apr 2025

Drug discovery explained: Chagas – How to prove treatments work?

Statements
16 Apr 2025

Statement from the Drugs for Neglected Diseases initiative (DNDi) on the conclusion of WHO Pandemic Agreement negotiations

Press releases
15 Apr 2025

New treatment for cryptococcal meningitis enters Phase II trial as global HIV funding cuts threaten to cause a massive increase in advanced HIV disease

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License